PPAR-ACTIVATING COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
A compound represented by the following formula (1): (wherein each of R 1 and R 2 , which may be identical to or different from each other, represents a hydrogen atom, a methyl group, or an ethyl group; each of R 3a , R 3b , R 4a , and R 4b , which may be identical to or different from each other, r...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
16.03.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A compound represented by the following formula (1):
(wherein each of R 1 and R 2 , which may be identical to or different from each other, represents a hydrogen atom, a methyl group, or an ethyl group; each of R 3a , R 3b , R 4a , and R 4b , which may be identical to or different from each other, represents a hydrogen atom, a halogen atom, a nitro group, a hydroxyl group, a C 1-4 alkyl group, a trifluoromethyl group, a C 1-4 alkoxy group, a C 1-4 alkylcarbonyloxy group, a di-C 1-4 alkylamino group, a C 1-4 alkylsulfonyloxy group, a C 1-4 alkylsulfonyl group, a C 1-4 alkylsulfinyl group, or a C 1-4 alkylthio group, or R 3a and R 3b , or R 4a and R 4b may be linked together to form an alkylenedioxy group; X represents an oxygen atom, a sulfur atom, or N-R 5 (R 5 represents a hydrogen atom, a C 1-4 alkyl group, a C 1-4 alkylsulfonyl group, or a C 1-4 alkyloxycarbonyl group); Y represents an oxygen atom, S(O) 1 (1 is a number of 0 to 2), a carbonyl group, a carbonylamino group, an aminocarbonyl group, a sulfonylamino group, or an aminosulfonyl group; Z represents CH or N; n is a number of 1 to 6; and m is a number of 2 to 6) or a salt thereof; and therapeutic drugs containing any of such a compound or salt. |
---|---|
AbstractList | A compound represented by the following formula (1):
(wherein each of R 1 and R 2 , which may be identical to or different from each other, represents a hydrogen atom, a methyl group, or an ethyl group; each of R 3a , R 3b , R 4a , and R 4b , which may be identical to or different from each other, represents a hydrogen atom, a halogen atom, a nitro group, a hydroxyl group, a C 1-4 alkyl group, a trifluoromethyl group, a C 1-4 alkoxy group, a C 1-4 alkylcarbonyloxy group, a di-C 1-4 alkylamino group, a C 1-4 alkylsulfonyloxy group, a C 1-4 alkylsulfonyl group, a C 1-4 alkylsulfinyl group, or a C 1-4 alkylthio group, or R 3a and R 3b , or R 4a and R 4b may be linked together to form an alkylenedioxy group; X represents an oxygen atom, a sulfur atom, or N-R 5 (R 5 represents a hydrogen atom, a C 1-4 alkyl group, a C 1-4 alkylsulfonyl group, or a C 1-4 alkyloxycarbonyl group); Y represents an oxygen atom, S(O) 1 (1 is a number of 0 to 2), a carbonyl group, a carbonylamino group, an aminocarbonyl group, a sulfonylamino group, or an aminosulfonyl group; Z represents CH or N; n is a number of 1 to 6; and m is a number of 2 to 6) or a salt thereof; and therapeutic drugs containing any of such a compound or salt. |
Author | OZAWA, HIDEFUMI OKUDA, AYUMU ABE, KAZUTOYO ARAKI, TAKAAKI ODA, SOICHI TOMA, TSUTOMU YAMAZAKI, YUKIYOSHI NISHIKAWA, MASAHIRO |
Author_xml | – fullname: ARAKI, TAKAAKI – fullname: OKUDA, AYUMU – fullname: TOMA, TSUTOMU – fullname: ABE, KAZUTOYO – fullname: NISHIKAWA, MASAHIRO – fullname: OZAWA, HIDEFUMI – fullname: YAMAZAKI, YUKIYOSHI – fullname: ODA, SOICHI |
BookMark | eNrjYmDJy89L5WRwDwhwDNJ1dA7xDHMM8fRzV3D29w3wD_VzUXAE4gAPxyBfR2fX0BBPZ0cfiFywZ4invx-Q7Rfi6OkH0hLs6OvKw8CalphTnMoLpbkZFNxcQ5w9dFML8uNTiwsSk1PzUkviPbwNDSyNLc1NHQ2NiVACAMMTLj0 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | HK1093975A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_HK1093975A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:57:17 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_HK1093975A13 |
Notes | Application Number: HK20060114278 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070316&DB=EPODOC&CC=HK&NR=1093975A1 |
ParticipantIDs | epo_espacenet_HK1093975A1 |
PublicationCentury | 2000 |
PublicationDate | 20070316 |
PublicationDateYYYYMMDD | 2007-03-16 |
PublicationDate_xml | – month: 03 year: 2007 text: 20070316 day: 16 |
PublicationDecade | 2000 |
PublicationYear | 2007 |
RelatedCompanies | KOWA CO., LTD |
RelatedCompanies_xml | – name: KOWA CO., LTD |
Score | 2.6732635 |
Snippet | A compound represented by the following formula (1):
(wherein each of R 1 and R 2 , which may be identical to or different from each other, represents a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | PPAR-ACTIVATING COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070316&DB=EPODOC&locale=&CC=HK&NR=1093975A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKepNp-L8ogfprUjtx9ZDkSxt1zn6wdaO3UaztbBLN7aK_77vdR960UPgkZBHEvLLS17yfgF4ER36trowFRUng6ITFLtCfVPUYp5pusgyKyfXQBCafqp_TI1pA5aHWJiaJ_SrJkdERM0R71W9Xq9_nFhO_bZy-yqWmLV69xLbkQ-nY2JjN2WnZ7tx5ERc5tz2h3I4sok1yeoYDA9KJ7SLJpp9d9KjoJT1b4viXcJpjMrK6goaedmCc374eK0FZ8H-vhvFPfS219CPYzZS6M3HhCWDsC_xKIijNHQkhin22Shg3E0T4jfYlY0H5H5COUzYIKQqYxa4NyB5bsJ9BVs0O_Z-5g-PbdduoVmuyvwOpHxhmVnX6ubEX44GJlvgzl8YBM9CE5ZoQ_tPNff_lD3Axc57qSmq-QjNavOZP6HZrcRzPWDftfeANA |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokbwawez22Lm2GCHxZRusAnrFhiEG1mhS7gMIjP--76OD73ooclLmzZt019f3-vrrwDPvC2_rc4sTcfFoLUkFDtcf9X0bJEaLZ6mtpCugZBZ_qT1PjNnFVgd3sKUPKFfJTkiImqBeC_K_Xrz48Ryy9jK7QtfYdb6rZc4rnqwjiUbu6W6XceLIzeiKqWOP1DZyJGsSXbbJGgonbTRIiwtpWlXPkrZ_NYovQs4jbGxvLiEisjrUKOHj9fqcBbu77tR3ENvewX9OCYjTcZ8TEkSsL5CozCOJsxVCKbYJ6OQUG-SSH6DXdk4kO4nlFlCAiarjEnoXYPS8xLqa9ij-XH0c39w7LtxA9V8nYtbUMTSttKO3RGSvxwVTLrEkz83JTwzg9u8AY0_m2n-U_YENT8Jh_NhwAZ3cL7zZBqabt1Dtfj4FA-oggv-WE7eN9l5gx4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PPAR-ACTIVATING+COMPOUND+AND+PHARMACEUTICAL+COMPOSITION+CONTAINING+SAME&rft.inventor=ARAKI%2C+TAKAAKI&rft.inventor=OKUDA%2C+AYUMU&rft.inventor=TOMA%2C+TSUTOMU&rft.inventor=ABE%2C+KAZUTOYO&rft.inventor=NISHIKAWA%2C+MASAHIRO&rft.inventor=OZAWA%2C+HIDEFUMI&rft.inventor=YAMAZAKI%2C+YUKIYOSHI&rft.inventor=ODA%2C+SOICHI&rft.date=2007-03-16&rft.externalDBID=A1&rft.externalDocID=HK1093975A1 |